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Abstract
Extra-intestinal pathogenic Escherichia coli (ExPEC) strains cause many diseases in humans and animals. While remaining
asymptomatic, they can colonize the intestine for subsequent extra-intestinal infection and dissemination in the
environment. We have previously identified the fos locus, a gene cluster within a pathogenicity island of the avian ExPEC
strain BEN2908, involved in the metabolism of short-chain fructooligosaccharides (scFOS). It is assumed that these sugars
are metabolized by the probiotic bacteria of the microbiota present in the intestine, leading to a decrease in the pathogenic
bacterial population. However, we have previously shown that scFOS metabolism helps BEN2908 to colonize the intestine,
its reservoir. As the fos locus is located on a pathogenicity island, one aim of this study was to investigate a possible role of
this locus in the virulence of the strain for chicken. We thus analysed fos gene expression in extracts of target organs of
avian colibacillosis and performed a virulence assay in chickens. Moreover, in order to understand the involvement of the fos
locus in intestinal colonization, we monitored the expression of fos genes and their implication in the growth ability of the
strain in intestinal extracts of chicken. We also performed intestinal colonization assays in axenic and Specific Pathogen-Free
(SPF) chickens. We demonstrated that the fos locus is not involved in the virulence of BEN2908 for chickens and is strongly
involved in axenic chicken cecal colonization both in vitro and in vivo. However, even if the presence of a microbiota does
not inhibit the growth advantage of BEN2908 in ceca in vitro, overall, growth of the strain is not favoured in the ceca of SPF
chickens. These findings indicate that scFOS metabolism by an ExPEC strain can contribute to its fitness in ceca but this
benefit is fully dependent on the bacteria present in the microbiota.
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Introduction
Extra-intestinal pathogenic E. coli (ExPEC) strains are respon-
sible for a wide range of diseases in humans and animals. These
strains have been isolated either from urinary tract infections,
neonatal meningitis, cases of septicaemia of various origins,
pneumonia, deep surgical wound infections and mastitis, or from
colibacillosis in poultry, a systemic infection that starts in the
respiratory tract [1–5]. This respiratory disease is characterized by
fibrinopurulent lesions of internal organs such as air sacculitis,
perihepatitis and pericarditis and is often associated with
septicaemia and mortality [6,7]. These extra-intestinal diseases
represent a serious economic, medical and veterinary burden [8].
ExPEC strains can asymptomatically colonize the intestinal
tract of humans and animals as commensal bacteria. Consequent-
ly, the intestine serves as a reservoir for pathogenic strains.
Intestinal colonization by ExPEC is thus a potential risk factor for
a subsequent extra-intestinal infection in the same host or for
dissemination of pathogens in the environment, thus leading to a
potential zoonotic risk [9–14]. The establishment of ExPEC in the
intestine appears to play an important role in their future
establishment in the urinary or respiratory tract. For instance,
strains involved in urinary tract infections gain access to the
periurethral area from the anus and establish infection in an
ascending manner [15]. Strains involved in neonatal meningitis
could translocate from the intestinal lumen of the neonate to the
blood stream, and poultry inhale pathogenic E. coli in dust derived
from faeces [6,7,16].
ExPEC strains mainly belong to the phylogenetical lineage B2
[2,17]. It has been shown that strains belonging to this
phylogenetic group have a greater ability to persist in the intestinal
tract of healthy or infected people [18–21]. It has been suggested
that virulence factors of ExPEC such as adhesins, or iron
acquisition factors could confer a higher capacity to colonize their
reservoir [18,19,22]. For example, the K5 capsule and P fimbriae
enhance intestinal colonization in gnotobiotic rats [23,24].
Moreover, the frz operon of the avian ExPEC strain BEN2908
and the pathogenicity islands of the uropathogenic strain 536 are
fitness elements involved in intestinal colonization [25,26].
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properties, one of the most important being metabolic compe-
tence, in addition to virulence factors. When two strains compete
for a limited nutrient, the one that is able to use it more efficiently
should outcompete the other [26,27].
We have recently shown that the ability of the strain BEN2908
to metabolize short-chain fructooligosaccharides (scFOS) enhances
colonization of the chicken intestine by bacteria during the first 8
days post-inoculation [28]. scFOS are natural linear polymers
comprising two to four b-(2-1)-linked fructosyl units, usually
attached to a terminal glucose residue [29]. Like many complex
plant carbohydrates, these sugars are not hydrolyzed by digestive
enzymes, and therefore they reach the distal parts of the intestine
intact where they are assimilated by the intestinal microbiota,
particularly probiotic bacteria [30,31].
The genomic region responsible for scFOS metabolism in the
BEN2908 strain, called the fos locus (GenBank accession
no. AY857617), is found on the AGI-3 pathogenicity island [32].
This locus is composed of six genes organized as an operon
encoding for a putative MFS (Major Facilitator Superfamily) sugar
transporter (FosT), two glycoside hydrolases of family 32 (FosE1
and FosE2), two proteins of unknown function (FosX and FosY), a
fructokinase (FosK), and of a divergently transcribed gene
encoding for a putative transcriptional regulator of the LacI/
GalR family (FosR). We previously defined a regulatory model of
scFOS metabolism in BEN2908 [33]. In the absence of scFOS,
FosR is able to bind to the promoter of the fos operon on two
operator sequences, suppressing fos gene expression. Moreover, fos
gene expression relies on catabolite repression, and the presence of
glucose represses this expression. It has also been shown that fos
gene expression depends on the presence of scFOS in the medium.
Due to the presence of the fos locus of the ExPEC strain
BEN2908 on the AGI-3 pathogenicity island, one aim of this study
was to investigate a possible role of these genes in the virulence of
BEN2908 for chickens by analysing fos gene expression in extracts
of target organs of avian colibacillosis and by performing a
virulence assay in chickens. Moreover, in order to study the
involvement of the fos locus in the colonization of the strain’s
reservoir, we analyzed fos gene expression and the implication of
these genes in the growth ability of BEN2908 in different intestinal
extracts. Finally, we performed intestinal colonization assays in
axenic and SPF (Specific Pathogen-Free) chickens. We found that
the fos locus is not involved in the virulence of BEN2908 for
chickens and that, even if this locus is strongly involved in axenic
chicken intestinal colonization in the ceca, it does not significantly
contribute to cecal colonization of SPF chickens.
Results
The fos locus is not involved in virulence
As the fos locus is located on the AGI-3 pathogenicity island
[32], we investigated a possible role of this locus in the virulence of
the BEN2908 strain for chicken. Firstly, we examined fos gene
expression in minimal media containing extracts of target organs
of avian colibacillosis including the lung, liver, spleen and
pericardial fluid. As the average body temperature of chicken is
41.5uC [34], we first checked the growth ability of the strain
BEN2908 in M9 minimal medium containing scFOS at 41.5uC.
Surprisingly, this strain was impaired in its ability to grow in this
minimal medium at 41.5uC compaired to 37uC (Fig. 1). This
impairment was also observed in M9 minimal medium containing
glucose but not in a more complex medium such as LB-Miller
medium (data not shown). As growth is altered in M9 minimal
medium at 41.5uC, we thus performed the experiments at 37uC.
Expression of fos genes was monitored by measuring the fos
promoter-mediated expression of luciferase from plasmid pQF52
during the growth of the BEN2908, BEN2908DfosT (unable to
metabolize scFOS) and BEN2908DfosR (unable to repress fos gene
expression) strains. As shown in Fig. 2, luciferase expression in
BEN2908 and BEN2908DfosT was always lower than in
BEN2908DfosR in all the media tested (5- to 31-fold higher in
BEN2908DfosR than in BEN2908 in the lung, 3- to 14-fold higher
in the liver, 14- to 36-fold higher in the spleen, and 3- to 14-fold
higher in pericardial fluid; 5- to 17-fold higher in BEN2908DfosR
than in BEN2908DfosT in the lung, 2- to 11-fold higher in the
liver, 7- to 22-fold higher in the spleen, and 2- to 12-fold higher in
pericardial fluid). This indicates that FosR repressed fos gene
expression in these organ extracts. Nevertheless, fos genes were
expressed slightly more in both BEN2908 and BEN2908DfosT in
minimal media containing liver extract and pericardial fluid (a
maximum of 1.2260.11610
6 and 1.7460.1610
6 RLU/OD450 in
the liver, 160.42610
6 and 1.3560.3610
6 RLU/OD450 in
pericardial fluid, versus 3.3460.4610
5 and 7.0760.7610
5
RLU/OD450 in the lung and 2.760.3610
5 and 5.3861.19610
5
RLU/OD450 in spleen extracts, respectively) (Fig. 2). This
expression was not due to the presence in the media of sugars
metabolized by the fos locus because it was not higher in BEN2908
than in BEN2908DfosT and there was no difference in the growth
of these strains. We then verified that the fos locus, whose genes
were slightly expressed in a minimal medium containing liver
extract, did not give a growth advantage to strain BEN2908 in the
presence of this colibacillosis target organ. Before, we checked that
the impairment of the BEN2908DfosT strain in scFOS metabolism
was only due to deletion of the fosT gene. We then introduced in
this strain a pGEM-T derivative containing the whole fos locus
[28]. As shown in Fig. 3, the recombinant BEN2908DfosT strain
was able to grow with scFOS as the sole carbon source. However,
this plasmid is unstable in M9 minimal medium containing organ
extracts (70–80% of the recombinant bacteria maintain the
plasmid during the growth, data not shown). As we performed
co-cultures to determine the implication of the fos locus in the
growth on such media, this instability did not allow us to realize
complementation assays in the presence of organ extracts. To
check the involvement of the fos locus in the presence of liver
extract, BEN2908 and BEN2908DfosT were inoculated together in
Figure 1. Growth of E. coli strain BEN2908 in the presence of
scFOS at 376C and 41.56C. Growth curves (OD450 nm) of strain
BEN2908 grown with shaking at 37uC (pink circle) or 41.5uC (purple
circle) in M9 minimal medium supplemented with 0.2% scFOS. The
average values and standard deviations result from three independent
experiments.
doi:10.1371/journal.pone.0035475.g001
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the proportion of each strain was monitored during their growth.
As shown in Fig. 4, BEN2908 did not outcompete BEN2908DfosT
in the presence of liver extract.
While these results strongly suggest that the fos locus is not
involved in virulence, the expression of fos genes was not studied in
blood and air sacs, which are other target organs/fluids of
colibacillosis. We thus examined the impact of the fos locus on the
virulence of the BEN2908 strain in vivo. To that end, equal
amounts of BEN2908 and BEN2908DfosT were co-inoculated into
the air-sac of SPF chickens (5610
6 CFU of each strain/chicken),
and the proportion of each strain in organs was monitored. As
shown in Fig. 5, there was no difference in the colonization of
target organs of avian colibacillosis (lung, thoracic air sac, liver,
spleen and pericardial fluid) by BEN2908 or BEN2908DfosT,a s
the competitive indexes did not differ significantly from 1. Overall,
these results demonstrate that the fos locus is not involved in the
virulence of BEN2908 for chicken.
fos genes are expressed in chicken cecal content and not
in intestinal mucus
The involvement of the fos locus in chicken intestinal
colonization has previously been demonstrated by monitoring
the proportion of BEN2908 and BEN2908DfosT in faeces [28].
However, identifying viable bacteria in faeces does not enable the
site(s) along the gastrointestinal tract in which the fos locus is
important to be determined. We thus investigated whether fos
genes were expressed in different parts of the distal intestine, i.e. in
intestinal mucus collected from the ileum or colon and in cecal
content of axenic chickens. As shown in Fig. 6A and B, luciferase
Figure 2. fos operon promoter activity in extracts of target organs of avian colibacillosis. Growth curves (OD450 nm) and relative
luminescence intensities (RLU/OD450 nm) of strains BEN2908, BEN2908DfosR and BEN2908DfosT carrying pQF52 grown without shaking at 37uCi nM 9
minimal medium supplemented with (A) 10% of lung extract, (B) 4% of liver extract, (C) 4% of spleen extract, (D) 4% of pericardial fluid. The RLU
average values and standard deviations result from three independent experiments.
doi:10.1371/journal.pone.0035475.g002
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lower in BEN2908 and BEN2908DfosT than in BEN2908DfosR
(7.5- to 12-fold higher in BEN2908DfosR than in BEN2908 in the
ileum, and 7- to 12.5-fold higher in the colon; 5- to 7-fold higher in
BEN2908DfosR than in BEN2908DfosT in the ileum, and 5.5- to 7-
fold higher in the colon). This indicates that no inducer was
present in these media to lift the FosR repression and to allow fos
gene expression. In cecal content, luciferase expression in
BEN2908 and BEN2908DfosT was much higher (a maximum of
2.360.25610
6 and 1.5360.2610
6 RLU/OD450 in cecal content,
respectively, versus 5.3260.49610
5 and 9.1962.21610
5 RLU/
OD450 in mucus from the ileum and 7.0361.45610
5 and
1.0560.4610
6 RLU/OD450 in mucus from the colon, respective-
ly), although lower than expression in BEN2908DfosR (1.5- to 7-
fold higher, and 1.5- to 11-fold higher in BEN2908DfosR,
respectively) (Fig. 6C). This indicates that expression in
BEN2908 and BEN2908DfosT was not fully activated. Moreover,
growth of BEN2908DfosT was less than that of BEN2908 and
BEN2908DfosR and luciferase expression was significantly higher
in BEN2908 than in BEN2908DfosT at different times (Fig. 6C)
[2.3060.25610
6 and 1.5360.2610
6 RLU/OD450 at 225 min
(p=0.014); 1.6760.28610
6 and 9.9261.94610
5 RLU/OD450
at 315 min (p=0.027); 1.3160.15610
6 and 7.5161.46610
5
RLU/OD450 at 360 min (p=0.01); 1.0860.05610
6 and
6.7161.63610
5 RLU/OD450 at 405 min (p=0.014); 6.466
1.05610
5 and 4.6460.32610
5 RLU/OD450 at 450 min
(p=0.045); 4.9760.87610
5 and 3.3260.44610
5 RLU/OD450 at
495 min (p=0.042); 3.7960.44610
5 and 2.4360.23610
5 RLU/
OD450 at 540 min (p=0.009), respectively]. This suggests that
inducers of fos gene expression are present in cecal content to
support BEN2908 growth and that this strain is able to metabolize
cecal nutrients via the fos locus.
For a better comparison of activation of fos gene expression
under all the conditions tested, we calculated the ratio of maximal
luciferase activity in BEN2908 to the maximal luciferase activity in
BEN2908DfosR. As shown in Fig. 7, maximal activation of the fos
promoter was observed in cecal content (54.767.3%). The fos
promoter was less activated in the presence of mucus from the
ileum and colon (9.560.4% and 10.662.2%, respectively) than in
the liver (23.761.4%), and was activated to the same extent in the
presence of pericardial fluid (13.965.1%). It was activated least in
the presence of lung and spleen extracts (5.860.5% and
6.561.5%, respectively).
The fos locus is involved in growth on cecal content from
axenic chicken in vitro and in vivo
As fos genes were expressed in cecal content, we then
investigated whether the fos locus benefited BEN2908 growth in
cecal content. We also investigated a possible role of this locus in
the growth of BEN2908 on intestinal mucus from the ileum and
colon. Indeed, although fos genes were not expressed in these
media, BEN2908 grew better than BEN2908DfosT in these
biological extracts when monitored independently during expres-
sion analyses (Fig. 6). To monitor the involvement of the fos locus
in the growth of BEN2908 in the presence of samples from the
Figure 3. Growth of E. coli strains BEN2908, BEN2908DfosT and
BEN2908DfosT/pGEM::fos in the presence of scFOS. Growth
curves (OD450 nm) of strains BEN2908 (pink circle), BEN2908DfosT (blue
triangle) and BEN2908DfosT/pGEM::fos (green square) grown with
shaking at 37uC in M9 minimal medium supplemented with 0.2%
scFOS. The average values and standard deviations result from three
independent experiments.
doi:10.1371/journal.pone.0035475.g003
Figure 4. Competition between E. coli strains BEN2908 and
BEN2908DfosT for growth in the presence of liver extract.
Growth curves (log10 CFU/ml) of strains BEN2908 (pink circle) and
BEN2908DfosT (blue triangle) grown without shaking at 37uCi nM 9
minimal medium supplemented with 4% of liver extract. The average
values and standard deviations result from three independent
experiments.
doi:10.1371/journal.pone.0035475.g004
Figure 5. Competition between E. coli strains BEN2908 and
BEN2908DfosT for colonization of chicken organs during avian
colibacillosis. Twenty five-day-old SPF White Leghorn chickens were
inoculated in the right air sac with strains BEN2908 and BEN2908DfosT
together (each at 5610
6 CFU/chicken). Animals were euthanized 48 h
post-inoculation by injection of Nesdonal and then necropsied. The
proportion of each strain in organs was monitored and CI were
calculated. Horizontal red bars indicate the median of CI and diamonds
indicate individual CI. Statistical analyses were conducted using the
Mann-Whitney U-test, measuring the difference between CI in organs
and in the inoculum. The calculated P values are presented.
doi:10.1371/journal.pone.0035475.g005
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were inoculated together into a minimal medium containing either
intestinal mucus from the ileum or colon, or cecal content from
axenic chickens. In the medium containing intestinal mucus from
the ileum, there was no difference between BEN2908 and
BEN2908DfosT during the exponential growth phase. From six
hours of growth, strain BEN2908 had a significant advantage over
BEN2908DfosT [8.5960.04 and 8.4360.05 log10 CFU/ml at
6 hours (p=0.017); 8.6360.02 and 8.4860.06 log10 CFU/ml at
7 hours (p=0.015); 8.7360.06 and 8.5660.06 log10 CFU/ml at
8 hours (p=0.023), respectively]. However, at 24 hours of growth,
this difference was no longer significant (Fig. 8A). In the medium
containing intestinal mucus from the colon, there was no
significant difference between BEN2908 and BEN2908DfosT
during the entire growth curve (Fig. 8B). Finally, in the medium
containing cecal content, there was a significant difference from
five hours of growth with a distinct advantage of BEN2908 over
BEN2908DfosT [8.2160.06 and 8.0360.02 log10 CFU/ml at
5 hours (p=0.008); 8.2860.02 and 8.1460.03 log10 CFU/ml at
6 hours (p=0.002); 8.3860.03 and 8.1460.02 log10 CFU/ml at
7 hours (p=0.0003); 8.4460.01 and 8.1960.04 log10 CFU/ml at
8 hours (p=0.0003); 8.6260.02 and 8.260.01 log10 CFU/ml at
24 hours (p=9.9610
26), respectively] (Fig. 8C). These results
indicate that the fos locus confers a slight growth advantage to
BEN2908 in ileal mucus and a more marked advantage in cecal
content from axenic chicken.
To confirm this involvement in this intestinal compartment, we
performed an in vivo experiment. BEN2908 and BEN2908DfosT
were fed together in equal amounts to axenic chickens (5610
7
CFU of each strain/chicken), and the proportion of each was
monitored in ceca. The results showed that the BEN2908 strain
had a strong advantage in cecal colonization compared to the
BEN2908DfosT strain up to eight days post-inoculation (median of
CI of 12.73 at 2 days post-feeding; 215 at 3 days; 2382.5 at 6 days
and 844.5 at 8 days) (Fig. 9A). This clearly indicates that the fos
locus is involved in the colonization of axenic chicken ceca.
The fos locus is involved in growth on cecal content in
the presence of a microbiota in vitro but not in vivo
All the previous experiments were conducted with biological
extracts from axenic chicken and do not represent the real
conditions encountered by the bacteria in vivo. Indeed, sugars
present in these extracts have not undergone any catabolism or
degradation by bacteria. The sugar contents in the chicken
intestine with a normal microbiota could be different. We thus
analyzed the involvement of the fos locus in the growth of
BEN2908 in cecal content from SPF chicken. When BEN2908
and BEN2908DfosT were inoculated together in a minimal
medium containing previously sterilized cecal content from SPF
chicken, there was no competition between the two strains,
indicating that the sugars metabolized via the fos locus had
previously been metabolized by the cecal microbiota (Fig. 8D).
This also suggests that competition observed in cecal content from
axenic chicken is a consequence of sugar metabolism mediated by
the fos locus.
In order to avoid the use of sugars metabolized by the fos locus
before sampling of cecal content but while looking at whether the
presence of cecal microbiota could inhibit the benefit conferred by
the fos locus, equal amounts of BEN2908 and BEN2908DfosT were
inoculated together into a minimal medium containing cecal
content from axenic chicken supplemented with cecal bacteria
from SPF chicken. We first verified that these cecal bacteria were
able to grow in a minimal medium containing cecal content from
axenic chicken, although the experiments were not carried out in
anaerobic conditions (8.97 log10 CFU/ml culturable on LB-Miller
medium at 24 h) (data not shown). As shown in Fig. 8E, there was
a significant difference after five hours of growth, with BEN2908
having a distinct advantage over BEN2908DfosT [8.3260.03 and
8.260.02 log10 CFU/ml at 5 hours (p=0.007); 8.4160.02 and
8.2660.04 log10 CFU/ml at 6 hours (p=0.003); 8.4560.03 and
8.360.02 log10 CFU/ml at 7 hours (p=0.002); 8.5060.03 and
8.3260.04 log10 CFU/ml at 8 hours (p=0.002); 8.7360.02 and
8.6360.004 log10 CFU/ml at 24 hours (p=0.0005), respectively].
These results demonstrate that the BEN2908 strain is able to
compete with a complex microbiota that also metabolizes the
substrate of the fos locus.
We then checked if these results could be observed in vivo.T o
that end, BEN2908 and BEN2908DfosT were fed together in equal
amounts to SPF chickens (5610
7 CFU of each strain/chicken),
and the proportion of each was monitored in ceca. We also
enumerated the total E. coli population in cecal content of each
animal. This population varied from one animal to the other (from
3.41610
5 to 1.24610
8 CFU/g of cecal content) (Table 2). As
shown in Fig. 9B, the BEN2908 strain had a slight advantage, but
not significant, in cecal colonization compared to the BEN2908D-
fosT strain at 3 days post-feeding but no advantage was observed
on other days (median of CI of 1 at 2 days post-feeding; 5.96 at 3
days; 1.24 at 6 days and 0.85 at 8 days) (Fig. 9B). These results
indicate that, in the presence of a complex microbiota, the fos locus
does not provide a benefit to the BEN2908 strain to colonize the
intestine.
Figure 6. fos operon promoter activity in extracts of chicken intestine. Growth curves (OD450 nm) and relative luminescence intensities (RLU/
OD450 nm) of strains BEN2908, BEN2908DfosR and BEN2908DfosT carrying pQF52 grown without shaking at 37uC in M9 minimal medium
supplemented with (A) intestinal mucus from the ileum at 2 mg/ml of proteins, (B) intestinal mucus from the colon at 2 mg/ml of proteins, (C) 2% of
cecal content. The RLU average values and standard deviations result from three independent experiments. Asterisks indicate significant differences
in mean luciferase activity between BEN2908 and BEN2908DfosT determined by a Student’s t-test. *** P,0.005; ** P,0.02; * P,0.05.
doi:10.1371/journal.pone.0035475.g006
Figure 7. Activation of fos promoter in chicken extracts or
physiological fluids. Percentage of fos promoter activation was
obtained by dividing the maximum luciferase expression in BEN2908 by
the maximum luciferase expression in BEN2908DfosR. The average
values and standard deviations result from three independent
experiments.
doi:10.1371/journal.pone.0035475.g007
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In this study, we demonstrated both in vitro and in vivo that the E.
coli strain BEN2908 had a strong growth advantage in cecal
content from axenic chicken over a strain that does not metabolize
scFOS (Fig. 6C, 8C and 9A). In the presence of a microbiota in
cecal content, we observed that, in vitro, the ability to metabolize
scFOS gave significant competitive advantage to the BEN2908
strain (Fig. 8E). However, in vivo in SPF chickens, overall, no
significant competitive advantage was observed but it is notable
Figure 8. Competition between E. coli strains BEN2908 and BEN2908DfosT to grow in the presence of extracts of chicken intestine.
Growth curves (log10 CFU/ml) of strains BEN2908 (pink circle) and BEN2908DfosT (blue triangle) grown without shaking at 37uC in M9 minimal
medium supplemented with (A) intestinal mucus from the ileum at 2 mg/ml of proteins, (B) intestinal mucus from the colon at 2 mg/ml of proteins,
(C) 2% of cecal content from axenic chicken, (D) 2% of cecal content from SPF chicken, (E) 4% of cecal content from axenic chicken supplemented
with cecal bacteria from SPF chicken. The average values and standard deviations result from three independent experiments. Asterisks indicate
significant differences in mean number of CFU between BEN2908 and BEN2908DfosT determined by a Student’s t-test. *** P,0.005; ** P,0.02;
* P,0.05.
doi:10.1371/journal.pone.0035475.g008
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another (Fig. 9B). As the cecum is an intestinal site where non-
digestible carbohydrates such as cellulose, inulin and FOS are
assimilated by the microbiota [35,36], we can assume that the
substrates giving a growth advantage to BEN2908 are scFOS.
These results thus suggest that scFOS metabolism by the
BEN2908 strain could contribute to its implantation in ceca.
Nevertheless, one of the most important factors determining the
nutrients found in the gastrointestinal tract is the presence of the
intestinal microbiota. The number of bacteria found in the ceca of
chicken is approximately 10
11 CFU/g, including Clostridiaceae,
Sporomusa, Enterobacteriaceae, Fusobacterium, Bacteroides, Lactobacillus,
Streptococcus, Ruminococcus and Bifidobacterium [37–40]. The presence
of these bacteria allows extensive bacterial fermentation, resulting
in further nutrient absorption, detoxification of harmful substances
and prevention of pathogen colonization [35,38,41]. Among these
bacteria, some strains of Lactobacillus, Bifidobacterium, Bacteroides and
Fusobacterium prausnitzii are able to metabolize nutrients such as
FOS [37,42–47]. These strains can therefore compete with the
BEN2908 strain to metabolize FOS nutrients in vivo. We have
previously shown that the fos locus of the BEN2908 strain was able
to give an advantage to this strain to colonize the intestine of SPF
chickens [28]. In this latter experiment, SPF chickens were
obtained by inoculating axenic chickens with a complex bacterial
inoculum consisting of a suspension of faeces from adult SPF hens
that have been conserved during several years at 280uC. In this
case, it is likely that there were no strict anaerobes in the faeces,
therefore any anaerobes inoculated to chickens. Similarly, in the in
vitro experiment performed in this study with the cecal content
from axenic chickens supplemented with cecal bacteria from SPF
chickens, it is possible that strict anaerobes did not survive during
sampling of cecal content and/or did not survive in the medium
because experiment was not achieve in anaerobic conditions. This
suggests that a strict anaerobic bacterium is able to metabolize
scFOS more efficiently than E. coli strain BEN2908.
During the intestinal colonization experiment in SPF chickens,
we observed that the E. coli population varied from one animal to
the other (Table 2). This suggests that, despite the fact that
chickens had the same diet and same environmental conditions,
the intestinal colonization by E. coli is highly variable. This
fluctuation is also observed for the strains BEN2908 and
BEN2908DfosT, the proportions of which in this total population
were inconstant (from 0.07 to 61.43% for BEN2908 and from 0.01
to 25.62% for BEN2908DfosT) (Table 2). Finally, we can also
observe that, in some animals, the BEN2908 strain was highly
dominant in the total E. coli population (61.43%, 43.12%, 50.70%
and 56.23% in chickens 75, 78, 83 and 85, respectively) whereas
the BEN2908DfosT strain proportion was lower (a maximum of
25.62% in the chicken 94) (Table 2). This observation suggests that
the fos locus, according to the bacteria present in the microbiota,
and more particularly in the absence of a particular anaerobic
bacterium able to metabolize scFOS most efficiently, is able to
contribute to intestinal colonization. It can nevertheless be noted
that, in few animals, and especially in chicken 90, the
BEN2908DfosT strain is able to outcompete the BEN2908 strain
(Table 2). As we have never observed this trend before, even in
minimal media containing only one carbon source, we cannot
currently explain this result in these animals.
It is noteworthy that the E. coli strain BEN2908 is fully able to
colonize experimentally the chicken intestine, even in SPF
animals. Conversely, commensal E. coli colonization cannot be
studied experimentally in conventional animals due to coloniza-
tion resistance, which results when all niches are filled by the
microbiota. Streptomycin-treated animals are thus routinely used
to study E. coli intestinal colonization [48]. The fact that BEN2908
is able to colonize SPF chicken intestine, without antibiotic
treatment and on a long range, strongly suggests that ExPEC
strains are better intestinal colonizers than commensal E. coli
strains. This is consistent with previous observations demonstrat-
ing that strains belonging to phylogenetical lineage B2 have a
greater ability to persist in the intestine [18–21].
In the present study, we investigated fos gene expression in
different biological extracts and we showed that fos gene expression
in cecal content was high in both the BEN2908 and BEN2908D-
fosT strain (Fig. 6C). This result is surprising since we previously
showed that fos gene expression depends on the presence of scFOS
[with b-(2-1) links] in the medium and that BEN2908DfosT is not
able to metabolize these carbohydrates [28,33]. Several hypoth-
Figure 9. Chicken cecal colonization by E. coli strains BEN2908 and BEN2908DfosT. Eleven-day-old axenic (A) and SPF (B) White Leghorn
chickens were fed with strains BEN2908 and BEN2908DfosT together (each at 5610
7 CFU/chicken). Animals were euthanized on days 2, 3, 6 and 8
post-inoculation by injection of Nesdonal and then necropsied. The proportion of each strain in animal cecal content was monitored over time and CI
were calculated. Horizontal red bars indicate the median of CI and diamonds indicate individual CI. Statistical analyses were conducted using the
Mann-Whitney U-test, measuring the difference between CI in cecal content and in the inoculum. The calculated P values are presented, with values
below 0.05 considered significant.
doi:10.1371/journal.pone.0035475.g009
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inulin and its derivatives, with one linear b(2-1)-linked fructosyl
chain attached to the fructosyl residue of the sucrose starter; neo-
series inulin with two linear b(2-1)-linked fructosyl chains, one
attached to the fructosyl residue of the sucrose, the other to the
glycosyl residue; levan with one linear b(2-6)-linked fructosyl chain
attached to the fructosyl residue of the sucrose starter; and
graminan with both b(2-1) and b(2-6) types of fructosyl linkages
[49]. One interesting hypothesis is that another type of fructan
induces fos gene expression. This inducer could enter via a
transporter other than FosT, explaining fos gene expression in
BEN2908DfosT. Another hypothesis to explain this result could be
the action of an activator of fos gene expression. We previously
demonstrated that fos gene expression also depends on catabolite
repression and the binding of CRP-cAMP complex to the fos
promoter region [33]. This binding enhances the ability of RNA
polymerase to bind and initiate transcription of fos genes. cAMP
synthesis is mediated by adenylate cyclase which is activated by
phosphorylated EIIA
Glc (IIA component of the glucose-specific
phosphoenolpyruvate:carbohydrate phosphotransferase system)
[50–53]. The phosphorylation state of EIIA
Glc depends on the
[phosphoenolpyruvate]/[pyruvate] ratio and is thus completely
dependent on the substrates metabolized by the cell and differs
according to the substrate [54]. In this study, fos gene expression in
the BEN2908DfosT strain was up to 36% in cecal content and
33% in liver extract (compared to the expression in the
BEN2908DfosR strain). Therefore, some substrates found in these
media, entering via the FosT transporter in the BEN2908 and
BEN2908DfosR strains, could lead to a lower [phosphoenolpyr-
uvate]/[pyruvate] ratio and thus lower concentrations of phos-
phorylated EIIA
Glc and cAMP synthesis in these strains. This
could also explain the high levels of expression in the
BEN2908DfosT strain compared to the expression in the
BEN2908DfosR strain. Another surprising result in this study is
that fos gene expression was always lower in BEN2908 than in
BEN2908DfosR, even in cecal content (Fig. 2 and 6). This indicates
that in none of the biological extracts tested, corresponding to the
conditions encountered by the bacteria in vivo, was there a
sufficient inducer concentration to allow a complete lift of FosR
repression, whereas previously we observed this situation in vitro
[33].
When this study was initiated, the fos locus had not been
identified in bacteria other than E. coli and its prevalence was low
(only 10 of the 133 E. coli strains tested possessed this locus [28]).
The subsequent release of newly discovered genome sequences in
databases enabled us to identify a truncated locus similar to the fos
locus in the genome of several pathogenic bacteria. Several
Klebsiella pneumoniae strains and Klebsiella variicola strain At-22
possess a truncated locus including a transcriptional regulator
sharing 77% identity with FosR, an MFS transporter sharing 85%
identity with FosT, and a glycosyl-hydrolase sharing 73% identity
with FosE1. This locus also comprises an intergenic region
between the regulator and the transporter that is very similar to
that of the fos locus (sharing 54% identity throughout the whole
region), including the same regulatory elements of operator 1 and
2 sequences and a CRP-cAMP recognition sequence. Moreover,
the Enterobacteriaceae bacterium 9_2_54FAA strain, isolated from
inflamed biopsy tissue from a patient with Crohn’s disease
[Enterobacteriaceae bacterium 9_2_54FAA Sequencing Project, Broad
Institute of Harvard and MIT (http://www.broadinstitute.org/)],
possesses a truncated locus similar to the fos locus with a
transcriptional regulator (73% identity with FosR), an MFS
transporter (89% identity with FosT), a glycosyl-hydrolase (67%
identity with FosE1), a protein of unknown function, and a
fructokinase (66% identity with FosK). It is well known that the
gastrointestinal tract of humans and animals is the reservoir of
commensal and pathogenic Enterobacteriaceae strains such as
Klebsiella [55–58]. This suggests that other pathogenic bacteria
could assimilate scFOS and that this metabolism could be
controlled by the same regulation mechanism as that of the fos
locus of BEN2908. Finally, we can thus postulate that, like the
BEN2908 strain, the ability to metabolize scFOS could also
enhance the ability of these pathogens to colonize their reservoir
according to the bacteria present in the intestinal microbiota.
In sum, as the importance of the fos locus is dependent on the
presence of the microbiota, and particularly on the presence of
specific anaerobic bacteria, it could be of interest to study the
involvement of this locus on intestinal colonization in different
avian lineage and in chicken fed with different diets, thus with
different intestinal microbiota, to determine if some conditions are
more favorable to a pathogenic strain to colonize its reservoir then
leading to greater dissemination of this strain in the local
environment, dust for example, and hence colonization of the
respiratory tract and pathogenesis.
Materials and Methods
Ethics statement
The housing, husbandry and slaughtering conditions complied
with European Union guidelines for the care and use of laboratory
animals. The experimental protocol for experimental colibacillosis
was approved by the regional ethics committee [Comite ´ d’Ethique
en Expe ´rimentation Animale (CEEA) Val de Loire] under number
CL2007-44. The experimental protocol for intestinal colonization
of chickens was approved by the regional ethics committee (CEEA
Val de Loire) under number CL2007-43.
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1.
E. coli strain BEN2908, O2:K1:H5 is a nalidixic acid-resistant
derivative of strain MT78 isolated from the trachea of a chicken
with a respiratory infection [59,60]. The fosT and fosR isogenic
mutants of BEN2908 were also used in this study [28,33]. Strains
were routinely grown in LB-Miller medium at 37uC with agitation
[61]. When necessary, antibiotics were used at the following
concentrations: nalidixic acid 30 mg/ml, ampicillin 100 mg/ml, or
kanamycin 50 mg/ml. For growth monitoring experiments,
overnight LB-Miller cultures of strains were washed twice and
resuspended in the same volume of M9 minimal medium [61].
The strains were then inoculated to an optical density (OD) at
450 nm of 0.05 and cultured at 37uC or 41.5uC with agitation in
20 ml of M9 medium supplemented with 0.2% scFOS (Profeed
P95; Beghin Meiji, France). scFOS powder is a mixture containing
small quantities of glucose, fructose and sucrose (5%), and larger
amounts of kestose (37%), nystose (63%) and fructofuranosyl
nystose (10%).
For expression analyses, overnight LB-Miller cultures of strains
carrying the pQF52 plasmid [33] were washed as described
previously. The strains were then inoculated to an OD at 450 nm
of 0.05 and cultured at 37uC without agitation in 20 ml of M9
medium supplemented with either 2% of cecal content, 4% of liver
or spleen extract, or 10% of lung extract, in 2.5 ml of M9 medium
supplemented with 4% of pericardial fluid, or in 1 ml of M9
medium supplemented with intestinal mucus adjusted at a final
protein concentration of 2 mg/ml as described by Edelman et al.
[62]. In these experiments, biological extracts were collected from
axenic chickens. For media containing pericardial fluid and
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dilutions onto LB-agar plates supplemented with ampicillin at
100 mg/ml at different times.
For co-cultures of BEN2908 and BEN2908DfosT, overnight LB-
Miller cultures were washed as described previously. The strains
were then inoculated in equivalent numbers (each corresponding
to an OD at 450 nm of 0.025) and cultured at 37uC without
agitation in 10 ml of M9 medium supplemented with either 2% of
cecal content from axenic or SPF chicken, 4% of cecal content
from axenic chicken supplemented with cecal microbiota of SPF
chicken, or 4% of liver extract, or in 0.3 ml of M9 medium
supplemented with intestinal mucus adjusted to a final protein
concentration of 2 mg/ml. At different times, serial dilutions were
plated onto LB-agar plates supplemented with nalidixic acid at
30 mg/ml (selection of BEN2908 and BEN2908DfosT strains) or
with kanamycin at 50 mg/ml (selection of the BEN2908DfosT
strain) for bacterial quantification. The number of CFU of
BEN2908 was calculated by subtracting the number of kanamy-
cin-resistant bacteria from the number of nalidixic acid-resistant
bacteria.
In all the experiments, the media supplemented with the
biological extracts were vigorously vortexed, centrifuged for 5 min
at 4,0006g, and supernatants were sterilized by filtration.
For the experiment with cecal bacteria, 100 ml of M9 minimal
medium containing cecal microbiota were inoculated in 10 ml of
M9 minimal medium supplemented with cecal content from
axenic chickens (representing 5610
5 CFU/ml, culturable on LB-
agar medium).
Table 1. Bacterial strains and plasmids used in this study.
Strain or plasmid Relevant characteristics Reference
E. coli strains
BEN2908 Extraintestinal pathogenic strain; O2:K1:H5; Nal
r Fos
+ Fim
+ Iut
+ IbeA
+ AGI-3
+, avian origin [59,60]
BEN2908DfosT Isogenic deletion mutant of BEN2908; Nal
r Kan
r Fos
2 [28]
BEN2908DfosR Isogenic deletion mutant of BEN2908; Nal
r Fos
+ [33]
Plasmids
pQF52 oripMB1 oripRO1600 Amp
r; luc under the control of the fos promoter [33]
pGEM::fos pGEM-T easy vector containing the whole fos locus; Amp
r [28]
doi:10.1371/journal.pone.0035475.t001
Table 2. Proportion of the BEN2908 and BEN2908DfosT strains in the total E. coli population in the cecal content of each SPF
chicken.
Chicken Days postfeeding
Total E. coli (CFU/g
of cecal content)
Proportion of BEN2908 in
the total E. coli population (%)
Proportion of BEN2908DfosT in
the total E. coli population (%) Competitive index
75 2 3.33610
7 61.43 9.11 5.92
76 2 1.00610
8 0.07 0.06 1.00
77 2 1.67610
7 2.57 6.07 0.37
78 2 1.68610
7 43.12 18.17 2.08
92 2 4.60610
7 5.95 9.41 0.56
79 3 2.25610
7 0.70 0.04 17.38
82 3 1.05610
8 5.59 0.78 6.28
83 3 1.46610
7 50.70 7.47 5.96
84 3 2.18610
7 2.76 5.07 0.48
91 3 4.36610
7 0.18 0.03 4.55
85 6 9.45610
6 56.23 9.90 4.99
87 6 6.85610
6 0.60 3.59 0.15
88 6 4.25610
6 0.45 0.47 0.84
89 6 9.09610
6 7.54 5.34 1.24
93 6 1.24610
8 0.11 0.01 9.10
80 8 1.85610
7 3.32 10.44 0.28
81 8 7.55610
7 1.85 0.03 56.05
86 8 3.05610
7 0.63 0.04 15.38
90 8 8.91610
7 0.10 10.71 0.01
94 8 3.41610
5 24.82 25.62 0.85
doi:10.1371/journal.pone.0035475.t002
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content, intestinal mucus and cecal microbiota
Liver, lung, spleen, pericardial fluid, cecal content and intestinal
mucus were collected from 25-day-old axenic PA12 White
Leghorn chickens from the Institut National de la Recherche
Agronomique experimental platform for infectious diseases.
Axenic PA12 White Leghorn chickens were obtained using the
method described by Le Bars [63]. Cecal content was also
collected from 25-day-old SPF PA12 White Leghorn chickens.
None antibiotic resistant E. coli strain was present in the intestine
of SPF chickens. Animals were euthanized by Nesdonal (Rho ˆne-
Me ´rieux, Lyon, France) injection in the occipital sinus. Organs
were collected and homogenized in sterile saline. Pericardial fluid
was collected with a Pasteur pipette and ceca were collected and
drilled to recover cecal content. Aliquots containing extracts of
organ, pericardial fluid or cecal content from axenic chicken were
stored at 220uC. Mucus was isolated from the ileum and from the
colon of chicken as described previously [64,65]. The animals
were fasted 20 h before isolating intestinal mucus. Briefly, colon
and ileum were collected and gently rinsed with PBS to remove
intestinal content. Mucus was isolated from the intestinal walls by
gentle scraping with the back of a scalpel, diluted 1:3 with 25 mM
HEPES (pH 7.2 to 7.5; Invitrogen) and vigorously vortexed.
Epithelial cells and large cell components were removed by
centrifugation at 11,0006g for 10 min at 4uC. The supernatant
was then centrifuged at 26,0006g for 15 min at 4uC, and aliquots
of the supernatant containing the crude mucus were stored at
220uC. The protein concentration of the mucus preparation was
determined using a Bradford protein assay (Biorad).
Cecal content from SPF chicken was preserved in glycerol at
280uC to conserve cecal bacteria. To collect cecal microbiota, this
cecal content was washed to remove cecal matter while
maintaining cecal bacteria. To that end, one volume of cecal
content was first diluted 1:10 in M9 minimal medium and
centrifuged 1 min at 2006 g. Supernatant was recovered,
centrifuged for 1 min at 3006g, then 2 min at 3006g. Finally,
the supernatant was centrifuged for 2 min at 16,0006g and the
pellet was resuspended with the same volume of M9 minimal
medium.
Luciferase measurements
Promoter activities of the fos operon in different media were
determined by firefly luciferase expression along the growth curve
as described previously [33]. Briefly, samples of 100 ml were taken
every 45 min, and light emission (relative light unit, RLU) was
recorded with a luminometer (Lumat LB 9507, Berthold). A
luciferase Assay System kit (Promega) was used with some
modifications. Samples were incubated with 300 ml of freshly
lysed buffer [16 CCLR (Cell Culture Lysis Reagent, Promega),
1.25 mg/ml lysozyme (Sigma), 2.5 mg/ml BSA (Sigma)] for
10 min with agitation at room temperature. Solutions were
quick-frozen in liquid nitrogen and then immediately incubated
at 37uC. After thawing, samples were incubated for 10 min with
agitation at room temperature. Finally, RLU was measured by
incubating 25 ml of cell lysate with 50 ml of Luciferase Assay
Reagent.
To compare levels of luciferase expression, a correlation curve
between OD at 450 nm and the number of bacterial CFU was
plotted for each strain. Numbers of CFU obtained in media
containing pericardial fluid and intestinal mucus were then
converted into OD values to normalize results.
Experimental colibacillosis
An in vivo virulence assay was conducted as described previously
with some modifications [32]. SPF chickens were obtained from
the Institut National de la Recherche Agronomique experimental
platform for infectious diseases. Fifteen 25-day-old SPF PA12
White Leghorn chickens were inoculated in the right thoracic air
sac with a 0.1 ml suspension containing a mixture of equal
numbers of BEN2908 and BEN2908DfosT (each approximately at
5610
6 CFU) in LB-Miller medium. The inoculum was prepared
from an overnight culture of each strain grown in 20 ml LB-Miller
medium at 37uC without agitation. Animals were euthanized 48 h
post-inoculation by injection with Nesdonal (Rho ˆne-Me ´rieux,
Lyon, France) in the occipital sinus and necropsied. A swab of the
left thoracic air sac was taken, and samples of the left lung, liver,
spleen and pericardial fluid were collected. After homogenization
in sterile saline, serial dilutions were plated onto Drigalski agar
plates (Biorad) supplemented with nalidixic acid at 30 mg/ml
(selection of BEN2908 and BEN2908DfosT strains) or with
kanamycin at 50 mg/ml (selection of the BEN2908DfosT strain)
for bacterial quantification. The number of CFU of BEN2908 was
calculated by subtracting the number of kanamycin-resistant
bacteria from the number of nalidixic-resistant bacteria. Compe-
tition indices (CI) were calculated following Freter et al.’s method
using BEN2908 as the reference strain [CI=(number of BEN2908
CFU/number of BEN2908DfosT CFU)/(number of BEN2908
CFU/number of BEN2908DfosT CFU in the initial inoculum)]
[66]. By definition, a CI of .1 indicates out-competition of the
mutant strain (BEN2908DfosT) by the wild-type reference strain
(BEN2908). A CI equal to 1 indicates no difference in colonization
of organs, and a CI of ,1 indicates out-competition of the wild-
type reference strain (BEN2908) by the mutant (BEN2908DfosT).
Intestinal colonization of chickens
An intestinal colonization assay was conducted as described
previously with some modifications [28]. Briefly, 16 axenic and 20
SPF 11-day-old PA12 White Leghorn chickens from the Institut
National de la Recherche Agronomique experimental platform for
infectious diseases were fed with a 0.5 ml suspension containing a
mixture of equal numbers of BEN2908 and BEN2908DfosT (each
approximately at 5610
7 CFU) in LB-Miller medium. None
antibiotic resistant E. coli strain was present in the intestine of SPF
chickens. The inoculum was prepared from an overnight culture of
each strain grown in 20 ml LB-Miller medium at 37uC without
agitation. Animals were euthanized on days 2, 3, 6 and 8 post-
inoculation by injection with Nesdonal in the occipital sinus and
necropsied. Ceca were collected and cecal contents were weighed
and then homogenized in sterile saline (9 ml/g of cecal content).
Viable E. coli cells were counted by plating 10-fold dilutions in
sterile saline on Drigalski agar plates (Biorad) supplemented with
nalidixic acid at 30 mg/ml (selection of BEN2908 and BEN2908D-
fosT strains) or with kanamycin at 50 mg/ml (selection of the
BEN2908DfosT strain). The number of CFU of BEN2908 was
calculated by subtracting the number of kanamycin-resistant
bacteria from the number of nalidixic-resistant bacteria. The
numbers of cecal CFU were calculated per gram of cecal content.
Competition indices (CI) were calculated as described before for
experimental colibacillosis.
In the intestinal colonization experiment of SPF chicken, total
E. coli population of cecal contents was counted by plating 10-fold
dilutions of cecal contents in sterile saline on Drigalski agar plates
(Biorad). In this experiment, we also verified that the kanamycin-
resistant E. coli population was also nalidixic acid-resistant and
unable to metabolize scFOS. To that end, kanamycin-resistant
colonies were picked on LB-Miller agar plates containing nalidixic
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resistant. Moreover, for each animal, kanamycin-resistant colonies
were pooled, resuspended in 10 ml of LB-Miller medium
containing kanamycin at 50 mg/ml and incubated overnight at
37uC with agitation. Overnight LB-Miller cultures were washed
twice in M9 minimal medium and resuspended in the same
volume of M9 minimal medium. Five milliliters of M9 minimal
medium supplemented with 0.2% scFOS were then inoculated
with 50 ml of the washed culture and incubated at 37uC with
agitation. No growth was observed for any of the pools tested.
Statistical analysis
Statistical analyses of CI were performed using the Mann-
Whitney U test. Exact P values were calculated with StatXact
software (version 5.0; Cytel Inc., Cambridge, MA). Statistical
analyses of luciferase expression and growth ability were
performed using a Student’s t-test.
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